The launch of BrightMeds GLP-1 signifies a vital shift in how healthcare providers manage type 2 diabetes . This novel medication class delivers a different way of working that also lowers sugar but can encourage weight loss and boost heart outcomes. Early data suggest it could be a a powerful to